[1]
|
Gambetti, P., Kong, Q., Zou, W., Parchi, P. and Chen, S.G. (2003) Sporadic and Familial CJD: Classification and Char-acterisation. British Medical Bulletin, 66, 213-239. https://doi.org/10.1093/bmb/66.1.213
|
[2]
|
Saá, P. (2020) Is Sporadic Creutzfeldt-Jakob Disease Transfusion-Transmissible? Transfusion, 60, 655-658.
https://doi.org/10.1111/trf.15763
|
[3]
|
Ritchie, D.L., Peden, A.H. and Barria, M.A. (2021) Variant CJD: Reflec-tions a Quarter of a Century on. Pathogens, 10, Article 1413. https://doi.org/10.3390/pathogens10111413
|
[4]
|
Salazar, R., Cerghet, M. and Ramachandran, V. (2014) Bilateral Hearing Loss Heralding Sporadic Creutzfeldt-Jakob Disease: A Case Report and Literature Review. Otology & Neu-rotology, 35, 1327-1329.
https://doi.org/10.1097/MAO.0000000000000485
|
[5]
|
Baiardi, S., Redaelli, V., Ripellino, P., Rossi, M., Frances-chini, A., Moggio, M., Sola, P., Ladogana, A., et al. (2019) Prion-Related Peripheral Neuropathy in Sporadic Creutz-feldt-Jakob Disease. Journal of Neurology, Neurosurgery and Psychiatry, 90, 424-427. https://doi.org/10.1136/jnnp-2018-319221
|
[6]
|
Manara, R., Fragiacomo, F., Ladogana, A., Vaianella, L., Campo-rese, G., Zorzi, G., Vicinanza, S., Zanusso, G., Pocchiari, M. and Cagnin, A. (2024) MRI Abnormalities in Creutz-feldt-Jakob Disease and Other Rapidly Progressive Dementia. Journal of Neurology, 271, 300-309. https://doi.org/10.1007/s00415-023-11962-1
|
[7]
|
Connor, A., Wang, H., Appleby, B.S. and Rhoads, D.D. (2019) Clinical Laboratory Tests Used to Aid in Diagnosis of Human Prion Disease. Journal of Clinical Microbiology, 57, e00769-19. https://doi.org/10.1128/JCM.00769-19
|
[8]
|
Kojima, G., Tatsuno, B.K., Inaba, M., Velligas, S., Masaki, K. and Liow, K.K. (2013) Creutzfeldt-Jakob Disease: A Case Report and Differential Diagnoses. Hawaiʻi Journal of Health & Social Welfare, 72, 136-139.
|
[9]
|
Pair, F.S. and Yacoubian, T.A. (2021) 14-3-3 Proteins: Novel Pharmaco-logical Targets in Neurodegenerative Diseases. Trends in Pharmacological Sciences, 42, 226-238. https://doi.org/10.1016/j.tips.2021.01.001
|
[10]
|
Llorens, F., Karch, A., Golanska, E., Schmitz, M., Lange, P., Si-korska, B., Liberski, P.P. and Zerr, I. (2017) Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutz-feldt-Jakob Disease: A Validation Study for Previously Established Cutoffs. Dementia and Geriatric Cognitive Disor-ders, 43, 71-80. https://doi.org/10.1159/000454802
|
[11]
|
Soomro, S. and Mohan, C. (2016) Biomarkers for Spo-radic Creutzfeldt-Jakob Disease. Annals of Clinical and Translational Neurology, 3, 465-72. https://doi.org/10.1002/acn3.304
|
[12]
|
Bongianni, M., Orrù, C., Groveman, B.R., Sacchetto, L., Fiorini, M., Tonoli, G., Triva, G., Capaldi, S., et al. (2017) Diagnosis of Human Prion Disease Using Real-Time Quaking-Induced Conver-sion Testing of Olfactory Mucosa and Cerebrospinal Fluid Samples. JAMA Neurology, 74, 155-162. https://doi.org/10.1001/jamaneurol.2016.4614
|
[13]
|
McGuire, L.I., Peden, A.H., Orrú, C.D., Wilham, J.M., Apple-ford, N.E., Mallinson, G., Andrews, M., Head, M.W., Caughey, B., Will, R.G., Knight, R.S. and Green, A.J. (2012) Re-al Time Quaking-Induced Conversion Analysis of Cerebrospinal Fluid in Sporadic Creutzfeldt-Jakob Disease. Annals of Neurology, 72, 278-285.
https://doi.org/10.1002/ana.23589
|
[14]
|
Miranda, L.H.L., Oliveira, A.F.P.H., Carvalho, D.M., Souza, G.M.F., Magalhães, J.G.M., Júnior, J.A.C., Lima, P.T.M.B.Q., Júnior, R.M.A., Filho, S.P.L. and Melo, H.M.A. (2022) System-atic Review of Pharmacological Management in Creutzfeldt-Jakob Disease: No Options So Far? Arquivos de Neu-ro-Psiquiatria, 80, 837-844.
https://doi.org/10.1055/s-0042-1755341
|
[15]
|
Karapetyan, Y.E., Sferrazza, G.F., Zhou, M., Ottenberg, G., Spicer, T., Chase, P., Fallahi, M., Hodder, P., Weissmann, C. and Lasmézas, C.I. (2013) Unique Drug Screening Approach for Prion Diseases Identifies Tacrolimus and Astemizole as Antiprion Agents. Proceedings of the National Academy of Sci-ences of the United States of America, 110, 7044-7049. https://doi.org/10.1073/pnas.1303510110
|
[16]
|
Trevitt, C.R. and Collinge, J. (2006) A Systematic Review of Prion Therapeutics in Experimental Models. Brain, 129, 2241-2265. https://doi.org/10.1093/brain/awl150
|
[17]
|
Weissmann, C. and Aguzzi, A. (2005) Approaches to Therapy of Prion Diseases. Annual Review of Medicine, 56, 321-344. https://doi.org/10.1146/annurev.med.56.062404.172936
|
[18]
|
Llorens, F., Rübsamen, N., Hermann, P., Schmitz, M., Villar-Piqué, A., Goebel, S., Karch, A. and Zerr, I. (2020) A Prognostic Model for Overall Survival in Sporadic Creutz-feldt-Jakob Disease. Alzheimer’s & Dementia, 16, 1438-1447. https://doi.org/10.1002/alz.12133
|